Iovance Biotherapeutics, Inc. (IOVA) Earnings Per Share (EPS)
Iovance Biotherapeutics, Inc. (IOVA) earnings per share history, EPS estimates, and growth trends. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2016-12-31 | N/A |
| 2017-12-31 | N/A |
| 2018-12-31 | N/A |
| 2019-12-31 | -$1.59 |
| 2020-12-31 | -$1.88 |
| 2021-12-31 | -$2.23 |
| 2022-12-31 | -$2.49 |
| 2023-12-31 | -$1.89 |
| 2024-12-31 | -$1.28 |
| 2025-12-31 | -$1.09 |
How IOVA compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| NEO | NeoGenomics Inc. | -$0.84 |
| ALLO | Allogene Therapeutics Inc. | -$0.87 |
| ALT | Altimmune Inc. | -$1.00 |
| BNTC | Benitec Biopharma Inc. | -$1.05 |
| ACHV | Achieve Life Sciences Inc. | -$1.25 |
These are five companies in the same sector as IOVA with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Iovance Biotherapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("IOVA")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | IOVA | $6.40 | +0.95% | 17.27M |
| 3 | ||||
| 4 | ||||
| 5 |